<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83253">
  <stage>Registered</stage>
  <submitdate>8/10/2008</submitdate>
  <approvaldate>21/11/2008</approvaldate>
  <actrnumber>ACTRN12608000586314</actrnumber>
  <trial_identification>
    <studytitle>Eye movement responses in dizzy patients and healthy controls.</studytitle>
    <scientifictitle>Comparison of spontaneous and provoked eye movement responses between dizzy patients and healthy controls.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>dizziness</healthcondition>
    <conditioncode>
      <conditioncode1>Ear</conditioncode1>
      <conditioncode2>Other ear disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Spontaneous and provoked eye movements  during provocative head tilts or rotations are recorded in dizzy patients with surface electrodes, and mask-mounted videocamera, and head motion sensor during the test time of approximately one hour . Head tilts are up to 45 degrees on each side, and head rotations are up to 30 degrees on each side.  These movements are well within the range used during natural locomotion. The test is performed once within one test session at 1 week, at 3 months and at 1 year after the treatment.</interventions>
    <comparator>Spontaneous and provoked eye movements  during provocative head tilts or rotations are recorded with surface electrodes, and mask-mounted videocamera, and head motion sensor during one test session of approximately one hour in healthy controls. The results of this single test session in controls is used for comparison with those of dizzy patients measured at three different time points. Head tilts are up to 45 degrees on each side, and head rotations are up to 30 degrees on each side.  These movements are well within the range used during natural locomotion.</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Abnormal nystagmus quantified with commercial three- dimensional video-oculography in three components.</outcome>
      <timepoint>at 1 week, at 3 months and at 1 year.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Unilateral weakness in caloric test will be analyzed from standard bithermal air provoked caloric nystagmus on each side using commercial video-oculography. Unilateral weakness is calculated by the software from the slow phase velocities of nystagmus during each stimuli.</outcome>
      <timepoint>at 1 week, at 3 months and at 1 year.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>peripheral dizziness</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>other neurotological diseases</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/08/2003</anticipatedstartdate>
    <actualstartdate>1/08/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Finland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr. Timo Hirvonen</primarysponsorname>
    <primarysponsoraddress>Haartmanstreet 4 E, 00029 Helsinki</primarysponsoraddress>
    <primarysponsorcountry>Finland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Helsinki University Central Hospital</fundingname>
      <fundingaddress>Haartmanstreet 4 E, 00029 Helsinki</fundingaddress>
      <fundingcountry>Finland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Helsinki University Central Hospital</sponsorname>
      <sponsoraddress>Haartmanstreet 4 E, 00029 Helsinki</sponsoraddress>
      <sponsorcountry>Finland</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The objective is to improve vestibular diagnostics in dizzy patients. The vestibular organ in inner ear senses motion, and controls eye movements to keep images stable. Vestibular dysfunction can be best characterized by comparing eye movement responses during motion stimuli.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics Committee of ophtalmology, otorhinolaryngology and neurosurgery</ethicname>
      <ethicaddress>Secretary Kirsi-Marja Ayravainen, Toolo Hospital, P.O.Box 266, 00029 Helsinki</ethicaddress>
      <ethicapprovaldate>16/10/2001</ethicapprovaldate>
      <hrec>138/2001</hrec>
      <ethicsubmitdate />
      <ethiccountry>Finland</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr. Timo Hirvonen</name>
      <address>Haartmanstreet 4 E, 00029 Helsinki</address>
      <phone>+35894711</phone>
      <fax />
      <email>timo.hirvonen@hus.fi</email>
      <country>Finland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr. Timo Hirvonen</name>
      <address>Haartmanstreet 4 E, 00029 Helsinki</address>
      <phone>+35894711</phone>
      <fax />
      <email>timo.hirvonen@hus.fi</email>
      <country>Finland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Timo Hirvonen</name>
      <address>Haartmanstreet 4 E, 00029 Helsinki</address>
      <phone>+35894711</phone>
      <fax />
      <email>timo.hirvonen@hus.fi</email>
      <country>Finland</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Timo Hirvonen</name>
      <address>Haartmanstreet 4 E, 00029 Helsinki  
</address>
      <phone>+35894711   </phone>
      <fax />
      <email>timo.hirvonen@hus.fi </email>
      <country>Finland</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>